Manufacturer profile
CEPHEID
Ecuador ARCSA·14 registered devices·Mar 16, 2012 – Oct 05, 2022
14
Total devices
2
Risk classes
2012
Earliest
2022
Latest
Recent registrations
Latest 10 ARCSA device registrations
Xpert ® Bladder Cancer Detection
92d1d6c1844052c420535bbc1d33b9e4
IIIOct 05, 2022
Xpert ® Bladder Cancer Monitor
e6c779f29b3739062f58d0a81ff0eb98
IIIOct 05, 2022
Xpert ® Breast Cancer STRAT4
dbf24e5a6483c1534bb08dcee63f34a1
IIIOct 05, 2022
Xpert Xpress CoV-2/FLU/RSV pus
46e8c549e6c9f06944cc74557e68ed25
IIIApr 20, 2022
Xpert Xpress CoV-2 plus
02fc1b68207035d0836c9c30e92e4dfc
IIIApr 20, 2022
Xpert® MTB/XDR
feb81cc0013eea3da959e08b75aa1238
IIIJan 05, 2022
Xpert Xpress Flu/RSV
384bfe264cb7c710ecf84eb5f76a0da1
IIIOct 15, 2020
Xpert® Xpress SARS-CoV-2
13c031c4132f35edff9ec1eea1ce44fe
IIIApr 02, 2020
Xpert Xpress Strep A
5598d9133faceb703685f4f076c64af3
IIIJan 27, 2020
Cepheid's Xpert BCR-ABL Ultra
ab1e797044a38f395a061ec7a7f19acf
IIIJul 27, 2016
Risk class distribution
Devices by risk class
II
1
7.1% of total
III
13
92.9% of total
About this profile
Explore comprehensive manufacturer profile for CEPHEID through Pure Global AI's free Ecuador medical device database. This company manufactures 14 medical devices registered with ARCSA across 2 risk classes. Their registration history spans from Mar 16, 2012 to Oct 05, 2022.